AllianceBernstein
MXCT icon

AllianceBernstein’s MaxCyte MXCT Stock Holding History

AllianceBernstein’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-100,100
Closed -$155K – 3397
2026
Q1 		$155K Hold
100,100
– – ﹤0.01% 3101
2025
Q4 		$155K Hold
100,100
– – ﹤0.01% 3109
2025
Q3 		$158K Hold
100,100
– – ﹤0.01% 3129
2025
Q2 		$218K Buy
100,100
+15,100
+18% +$36.6K ﹤0.01% 3025
2025
Q1 		$232K Hold
85,000
– – ﹤0.01% 2878
2024
Q4 		$354K Hold
85,000
– – ﹤0.01% 2791
2024
Q3 		$331K Hold
85,000
– – ﹤0.01% 2871
2024
Q2 		$333K Buy
85,000
+21,910
+35% +$94.3K ﹤0.01% 2874
2024
Q1 		$264K Hold
63,090
– – ﹤0.01% 2847
2023
Q4 		$297K Sell
63,090
-4,530
-7% -$17.6K ﹤0.01% 2850
2023
Q3 		$211K Buy
67,620
+6,030
+10% +$24.2K ﹤0.01% 2941
2023
Q2 		$283K Buy
61,590
+20,390
+49% +$93.7K ﹤0.01% 2889
2023
Q1 		$204K Buy
41,200
+6,200
+18% +$30.5K ﹤0.01% 2900
2022
Q4 		$191K Buy
35,000
+17,000
+94% +$104K ﹤0.01% 3019
2022
Q3 		$117K Buy
18,000
+6,400
+55% +$35.7K ﹤0.01% 3104
2022
Q2 		$55K Buy
+11,600
New +$57.1K ﹤0.01% 3167

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

AllianceBernstein's MXCT Position: Q2 2026 in Review

AllianceBernstein sold out of MaxCyte (MXCT) in Q2 2026, closing a stake of 100,100 shares — an estimated $155K sold.

AllianceBernstein first reported a position in MXCT in Q2 2022 and held it in 16 quarters. The position peaked at $354K in Q4 2024. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • AllianceBernstein reported no remaining MaxCyte position as of Q2 2026 after selling out during the quarter.
  • AllianceBernstein sold 100,100 MaxCyte shares in Q2 2026, an estimated $155K.
  • AllianceBernstein first reported a position in MaxCyte in Q2 2022 and held it in 16 quarters.
  • AllianceBernstein's MaxCyte position peaked at $354K in Q4 2024.
  • 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.